An effective anti-emetic regimen for less than $2 USD: A prospective observational study
| Autor: | Selvaluxmy Ganesharajah, Jayachandran P K, Trivadi S. Ganesan, Prasanth Ganesan, Nikita Mehra, Tenali Gnana Sagar, Venkatraman Radhakrishnan, Manikandan Dhanushkodi |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Olanzapine
Cancer Research medicine.medical_specialty Chemotherapy Schedule business.industry medicine.medical_treatment 03 medical and health sciences Regimen 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Internal medicine medicine Anti-emetic Observational study business 030215 immunology Chemotherapy-induced nausea and vomiting medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 36:e22194-e22194 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2018.36.15_suppl.e22194 |
| Popis: | e22194Background: Olanzapine is an effective agent for chemotherapy induced nausea and vomiting (CINV). The usual dose is 10 mg X 4 days when chemotherapy is given in a Q 3-4 weekly schedule. We re... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|